Anna Cyranka

Anna Cyranka joined Alvotech in 2022. She has been involved in the biosimilars business since the early start of her career in the biotech industry.

With more than 15 years experience and a strong scientific background, she is responsible for developing and maintaining a best-in-class portfolio for Alvotech, satisfying both the needs of patients and our commercial partners. Working closely with all functions within the company, Anna and her team oversee everyday program activity, ensuring both prompt delivery and that key portfolio decisions support our long-term strategy.

Prior to joining Alvotech, Anna worked at Polpharma Biologics in various managerial roles, including heading the R&D department, where she contributed to the company's first biosimilars approvals. Earlier on, she was also involved in startups offering contract services to European large pharma companies.

Anna holds a PhD in Biotechnology from ETH Zurich, Switzerland and an MBR degree from Gdansk Technical University, Poland.